DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation

REFERENCES

• Appella, E., and C. W. Anderson. 2001. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2764–2772.
   PubMedGoogle Scholar
• Atadja, P., H. Wong, I. Garkavtsev, C. Veillette, and K. Riabowol. 1995. Increased activity of p53 in senescing fibroblasts. Proc. Natl. Acad. Sci. USA 92:8348–8352.
   PubMed Web of Science ®Google Scholar
• Badciong, J. C., and A. L. Haas. 2002. MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination. J. Biol. Chem. 277:49668–49675.
   PubMedGoogle Scholar
• Banin, S., L. Moyal, S. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674–1677.
   PubMed Web of Science ®Google Scholar
• Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12:461–468.
   PubMed Web of Science ®Google Scholar
• Caspari, T. 2000. How to activate p53. Curr. Biol. 10:R315–317.
   PubMed Web of Science ®Google Scholar
• Danovi, D., E. Meulmeester, D. Pasini, D. Migliorini, M. Capra, R. Frenk, P. de Graaf, S. Francoz, P. Gasparini, A. Gobbi, K. Helin, P. G. Pelicci, A. G. Jochemsen, and J. C. Marine. 2004. Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol. Cell. Biol. 24:5835–5843.
   PubMed Web of Science ®Google Scholar
• de Graaf, P., N. A. Little, Y. F. Ramos, E. Meulmeester, S. J. Letteboer, and A. G. Jochemsen. 2003. Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2. J. Biol. Chem. 278:38315–38324.
   PubMed Web of Science ®Google Scholar
• Dougherty, M. K., and D. K. Morrison. 2004. Unlocking the code of 14-3-3. J. Cell Sci. 117:1875–1884.
   PubMedGoogle Scholar
• Finch, R. A., D. B. Donoviel, D. Potter, M. Shi, A. Fan, D. D. Freed, C. Y. Wang, B. P. Zambrowicz, R. Ramirez-Solis, A. T. Sands, and N. Zhang. 2002. mdmx is a negative regulator of p53 activity in vivo. CancerRes 62:3221–3225.
   Google Scholar
• Gentiletti, F., F. Mancini, M. D'Angelo, A. Sacchi, A. Pontecorvi, A. G. Jochemsen, and F. Moretti. 2002. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts. Oncogene 21:867–877.
   PubMedGoogle Scholar
• Gu, J., H. Kawai, L. Nie, H. Kitao, D. Wiederschain, A. G. Jochemsen, J. Parant, G. Lozano, and Z. M. Yuan. 2002. Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J. Biol. Chem. 277:19251–19254.
   PubMed Web of Science ®Google Scholar
• Iliakis, G., Y. Wang, J. Guan, and H. Wang. 2003. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22:5834–5847.
   PubMed Web of Science ®Google Scholar
• Jackson, M. W., and S. J. Berberich. 2000. MdmX protects p53 from Mdm2-mediated degradation. Mol. Cell. Biol. 20:1001–1007.
   PubMedGoogle Scholar
• Juven-Gershon, T., and M. Oren. 1999. Mdm2: the ups and downs. Mol. Med. 5:71–83.
   PubMed Web of Science ®Google Scholar
• Kawai, H., D. Wiederschain, H. Kitao, J. Stuart, K. K. Tsai, and Z. M. Yuan. 2003. DNA damage-induced MDMX degradation is mediated by MDM2. J. Biol. Chem. 278:45946–45953.
   PubMed Web of Science ®Google Scholar
• Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054–1072.
   PubMed Web of Science ®Google Scholar
• Kulju, K. S., and J. M. Lehman. 1995. Increased p53 protein associated with aging in human diploid fibroblasts. Exp. Cell Res. 217:336–345.
   PubMedGoogle Scholar
• Lane, D. P., and P. A. Hall. 1997. MDM2-arbiter of p53's destruction. Trends Biochem. Sci. 22:372–374.
   PubMed Web of Science ®Google Scholar
• Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323–331.
   PubMed Web of Science ®Google Scholar
• Li, C., L. Chen, and J. Chen. 2002. DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms. Mol. Cell. Biol. 22:7562–7571.
   PubMed Web of Science ®Google Scholar
• Li, M., C. L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu. 2003. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302:1972–1975.
   PubMed Web of Science ®Google Scholar
• Linares, L. K., A. Hengstermann, A. Ciechanover, S. Muller, and M. Scheffner. 2003. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc. Natl. Acad. Sci. USA 100:12009–12014.
   PubMed Web of Science ®Google Scholar
• Maya, R., M. Balass, S. T. Kim, D. Shkedy, J. F. Leal, O. Shifman, M. Moas, T. Buschmann, Z. Ronai, Y. Shiloh, M. B. Kastan, E. Katzir, and M. Oren. 2001. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15:1067–1077.
   PubMed Web of Science ®Google Scholar
• McCurrach, M. E., and S. W. Lowe. 2001. Methods for studying pro- and antiapoptotic genes in nonimmortal cells. Methods Cell Biol. 66:197–227.
   PubMedGoogle Scholar
• Meek, D. W. 2004. The p53 response to DNA damage. DNA Repair (Amsterdam) 3:1049–1056.
   PubMed Web of Science ®Google Scholar
• Meulmeester, E., R. Frenk, R. Stad, P. de Graaf, J. C. Marine, K. H. Vousden, and A. G. Jochemsen. 2003. Critical role for a central part of Mdm2 in the ubiquitylation of p53. Mol. Cell. Biol. 23:4929–4938.
   PubMed Web of Science ®Google Scholar
• Migliorini, D., D. Danovi, E. Colombo, R. Carbone, P. G. Pelicci, and J. C. Marine. 2002. Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. J. Biol. Chem. 277:7318–7323.
   PubMed Web of Science ®Google Scholar
• Migliorini, D., E. L. Denchi, D. Danovi, A. Jochemsen, M. Capillo, A. Gobbi, K. Helin, P. G. Pelicci, and J. C. Marine. 2002. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol. Cell. Biol. 22:5527–5538.
   PubMed Web of Science ®Google Scholar
• Momand, J., H. H. Wu, and G. Dasgupta. 2000. MDM2-master regulator of the p53 tumor suppressor protein. Gene 242:15–29.
   PubMed Web of Science ®Google Scholar
• Oda, K., H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura, and Y. Taya. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102:849–862.
   PubMed Web of Science ®Google Scholar
• Olivier, M., R. Eeles, M. Hollstein, M. A. Khan, C. C. Harris, and P. Hainaut. 2002. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum. Mutat. 19:607–614.
   PubMed Web of Science ®Google Scholar
• Pan, Y., and J. Chen. 2003. MDM2 promotes ubiquitination and degradation of MDMX. Mol. Cell. Biol. 23:5113–5121.
   PubMed Web of Science ®Google Scholar
• Parant, J., A. Chavez-Reyes, N. A. Little, W. Yan, V. Reinke, A. G. Jochemsen, and G. Lozano. 2001. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat. Genet. 29:92–95.
   PubMed Web of Science ®Google Scholar
• Pereg, Y., D. Shkedy, P. de Graaf, E. Meulmeester, M. Edelson-Averbukh, M. Salek, S. Biton, A. F. Teunisse, W. D. Lehmann, A. G. Jochemsen, and Y. Shiloh. 2005. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage. Proc. Natl. Acad. Sci. USA 102:5056–5061.
   PubMed Web of Science ®Google Scholar
• Pochampally, R., B. Fodera, L. Chen, W. Lu, and J. Chen. 1999. Activation of an MDM2-specific caspase by p53 in the absence of apoptosis. J. Biol. Chem. 274:15271–15277.
   PubMedGoogle Scholar
• Prives, C. 1998. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95:5–8.
   PubMed Web of Science ®Google Scholar
• Ramos, Y. F., R. Stad, J. Attema, L. T. Peltenburg, A. J. van der Eb, and A. G. Jochemsen. 2001. Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53. Cancer Res 61:1839–1842.
   PubMed Web of Science ®Google Scholar
• Riemenschneider, M. J., R. Buschges, M. Wolter, J. Reifenberger, J. Bostrom, J. A. Kraus, U. Schlegel, and G. Reifenberger. 1999. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res 59:6091–6096.
   PubMed Web of Science ®Google Scholar
• Sabbatini, P., and F. McCormick. 2002. MDMX inhibits the p300/CBP-mediated acetylation of p53. DNA Cell Biol. 21:519–525.
   PubMedGoogle Scholar
• Sancar, A., L. A. Lindsey-Boltz, K. Unsal-Kacmaz, and S. Linn. 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73:39–85.
   PubMed Web of Science ®Google Scholar
• Sarkaria, J. N., E. C. Busby, R. S. Tibbetts, P. Roos, Y. Taya, L. M. Karnitz, and R. T. Abraham. 1999. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 59:4375–4382.
   PubMed Web of Science ®Google Scholar
• Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602.
   PubMed Web of Science ®Google Scholar
• Sharp, D. A., S. A. Kratowicz, M. J. Sank, and D. L. George. 1999. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J. Biol. Chem. 274:38189–38196.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984–2991.
   PubMed Web of Science ®Google Scholar
• Shinozaki, T., A. Nota, Y. Taya, and K. Okamoto. 2003. Functional role ofMdm2 phosphorylation by ATR in attenuation of p53 nuclear export. Oncogene 22:8870–8880.
   PubMed Web of Science ®Google Scholar
• Shvarts, A., W. T. Steegenga, N. Riteco, T. van Laar, P. Dekker, M. Bazuine, R. C. van Ham, W. van der Houven van Oordt, G. Hateboer, A. J. van der Eb, and A. G. Jochemsen. 1996. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 15:5349–5357.
   PubMed Web of Science ®Google Scholar
• Stad, R., N. A. Little, D. P. Xirodimas, R. Frenk, A. J. van der Eb, D. P. Lane, M. K. Saville, and A. G. Jochemsen. 2001. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2:1029–1034.
   PubMed Web of Science ®Google Scholar
• Stad, R., Y. F. Ramos, N. Little, S. Grivell, J. Attema, A. J. van Der Eb, and A. G. Jochemsen. 2000. Hdmx stabilizes Mdm2 and p53. J. Biol. Chem. 275:28039–28044.
   PubMed Web of Science ®Google Scholar
• Stommel, J. M., and G. M. Wahl. 2005. A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation. Cell Cycle 4:411–417.
   PubMed Web of Science ®Google Scholar
• Tanimura, S., S. Ohtsuka, K. Mitsui, K. Shirouzu, A. Yoshimura, and M. Ohtsubo. 1999. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett. 447:5–9.
   PubMed Web of Science ®Google Scholar
• Taya, Y., K. Nakajima, K. Yoshizawa-Kumagaye, and K. Tamai. 2003. Generation and application of phospho-specific antibodies for p53 and pRB, p. 17–26. In W. S. El-Deiry (ed.), Tumor suppressor genes: regulation, function, and medical applications. Humana Press, Inc., Totowa, N.J.
   Google Scholar
• Tzivion, G., Y. H. Shen, and J. Zhu. 2001. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20:6331–6338.
   PubMed Web of Science ®Google Scholar
• van Hemert, M. J., H. Y. Steensma, and G. P. van Heusden. 2001. 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23:936–946.
   PubMed Web of Science ®Google Scholar
• Vousden, K. H., and X. Lu. 2002. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2:594–604.
   PubMed Web of Science ®Google Scholar
• Waterman, M. J., E. S. Stavridi, J. L. Waterman, and T. D. Halazonetis. 1998. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat.Genet. 19:175–178.
   PubMed Web of Science ®Google Scholar
• Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126–1132.
   PubMed Web of Science ®Google Scholar